Cargando…
Critical Evaluation of the Use of Cell Cultures for Inclusion in Clinical Trials of Patients Affected by Collagen VI Myopathies
Collagen VI myopathies (Ullrich congenital muscular dystrophy (UCMD), Bethlem myopathy (BM), and myosclerosis myopathy) share a common pathogenesis, that is, mitochondrial dysfunction due to deregulation of the permeability transition pore (PTP). This effect was first identified in the Col6a1(−/−) m...
Autores principales: | Sabatelli, P, Palma, E, Angelin, A, Squarzoni, S, Urciuolo, A, Pellegrini, C, Tiepolo, T, Bonaldo, P, Gualandi, F, Merlini, L, Bernardi, P, Maraldi, NM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Subscription Services, Inc., A Wiley Company
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415679/ https://www.ncbi.nlm.nih.gov/pubmed/21953374 http://dx.doi.org/10.1002/jcp.23039 |
Ejemplares similares
-
Defective collagen VI α6 chain expression in the skeletal muscle of patients with collagen VI-related myopathies
por: Tagliavini, F., et al.
Publicado: (2014) -
Monoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies
por: Sorato, E., et al.
Publicado: (2014) -
Expression of collagen VI α5 and α6 chains in human muscle and in Duchenne muscular dystrophy-related muscle fibrosis
por: Sabatelli, Patrizia, et al.
Publicado: (2012) -
Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies
por: Bovolenta, Matteo, et al.
Publicado: (2010) -
New Clinical and Immunofluoresence Data of Collagen VI-Related Myopathy: A Single Center Cohort of 69 Patients
por: Merlini, Luciano, et al.
Publicado: (2023)